Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 29 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

10%

3 trials in Phase 3/4

Results Transparency

0 of 12 completed trials have results

Key Signals

4 recruiting

Enrollment Performance

Analytics

N/A

15(62.5%)

Early Phase 1

3(12.5%)

Phase 3

2(8.3%)

Phase 1

2(8.3%)

Phase 2

1(4.2%)

Phase 4

1(4.2%)

24Total

N/A(15)

Early Phase 1(3)

Phase 3(2)

Phase 1(2)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (29)

Showing 20 of 29 trials

NCT07328113Completed

Interleukin-6 and Thyroid Dysfunction in Hemodialysis Patients

Role: lead

NCT07298304Not ApplicableCompleted

Impact of Sorghum Rice on Beta-Cell Function and Insulin Resistance in Prediabetes

Role: lead

NCT07266961Not ApplicableCompleted

Low-BFR vs Moderate-Intensity Resistance Training on Cardiorespiratory Fitness in Elderly Women

Role: lead

NCT03775460Not ApplicableActive Not Recruiting

Methotrexate and Prednisolone Study in Erythema Nodosum Leprosum

Role: collaborator

NCT07134595Not ApplicableRecruiting

Comparing Conventional Continuous Ambulatory Peritoneal Dialysis Prescription (C-CAPD) With Modified-CAPD (M-CAPD) Prescription in Children With End-stage Kidney Disease From Low-resource Settings

Role: collaborator

NCT06975943Not ApplicableActive Not Recruiting

Comparison in Cervical Length and Prolongation of Gestation Age on Vaginal Progesterone Administration to Pregnant Women After the Acute Phase of Threatened Preterm Birth

Role: lead

NCT06935630Not ApplicableRecruiting

Comparison of The Effect of 5-MTHF and Folic Acid Supplementation in Increasing Red Blood Cell Folate in Pregnant Women

Role: lead

NCT06553417Not ApplicableCompleted

Emollient 'Plus' vs Urea 10% for Mild-Moderate Atopic Dermatitis

Role: lead

NCT06282692Phase 3Recruiting

INAVAC Vaccine Phase III (Immunobridging Study) in Healthy Population Aged 12 to 17 Years Old

Role: lead

NCT06272253Early Phase 1Active Not Recruiting

UNAIR Inactivated COVID-19 Vaccine INAVAC as Heterologue Booster (Immunobridging Study) in Adolescent Subjects

Role: lead

NCT06259578Early Phase 1Recruiting

UNAIR Inactivated COVID-19 Vaccine as Homologue Booster (Immunobridging Study)

Role: lead

NCT06139679Completed

Improvement In Left Ventricular Diameter After Closure Of ASD With Fenestrated Patch: A Cross-sectional Study

Role: lead

NCT05918939Early Phase 1Unknown

UNAIR Inactivated COVID-19 Vaccine as Heterologue Booster (Immunobridging Study)

Role: lead

NCT05226429Phase 1Unknown

UNAIR Inactivated COVID-19 Vaccine

Role: lead

NCT05652556Unknown

Quinolone Resistance Profiles and Mechanisms of Staphylococcus Aureus and Escherichia Coli From Humans, Chicken and Catfish Farms in Indonesia

Role: collaborator

NCT05124340Phase 2Completed

Safety and Tuberculin Conversion Following BCG Vaccination

Role: collaborator

NCT05508477Phase 3Unknown

UNAIR Inactivated COVID-19 Vaccine Phase III (Immunobridging Study)

Role: lead

NCT05465499Completed

Preliminary Survey in Preparation for the Implementation of ERAS at Dr Soetomo Hospital

Role: lead

NCT05254249Phase 1Unknown

Clinical Trial of Probiotic Supplementation in Psoriasis Vulgaris

Role: lead

NCT05246124Not ApplicableCompleted

The Effect of Demographic, Mental, and Physical Activity Profiles Towards Burnout in Frontline Healthcare Workers Facing COVID-19 Pandemics in Dr. Soetomo General Hospital Surabaya

Role: lead